The European Union represents one of the world’s most valuable and influential cosmetics markets, valued…
News
From EMC to GPSR: A Tailored Compliance Journey into the EU and the UK
HELLO CHAKRA LLC, a U.S.-based wellness brand, set out to expand into the EU and UK with a new product line under the General Product Safety Regulation (GPSR). With expert guidance from Obelis Group they successfully navigated product classification, documentation, and compliance—ensuring a confident and well-prepared market entry.
1st June 2025 deadline of Quebec’s Bill 96 and its impact on Cosmetics Businesses
In June 2022, Quebec passed Bill 96, An Act respecting French, the official and common language of Québec, which amended the Charter of the French Language. These amendments significantly affect labelling and advertising requirements for businesses, including those in the cosmetics industry.
TrailHeads Enters EU Market with Obelis Compliance Support
TrailHeads, a U.S. outdoor brand, partnered with Obelis Group to navigate GPSR compliance and launch successfully in the EU, overcoming Amazon-related challenges and accelerating their market entry.
Medical Devices (Pvt) Ltd.: Seamless Market Access, Powered by Partnership
Medical Devices (Pvt) Ltd. partnered with Obelis Group to overcome regulatory challenges and successfully launch in the EU, UK, and Swiss markets with expert support and streamlined compliance.
May 2025 cosmetics ban deadline in the EU
From May 2025, the EU bans 3-(4′-methylbenzylidene)-camphor in cosmetics. Learn what this means for product compliance and how beauty brands should prepare.
Legacy requirements: 26 May 2025 deadline for in-vitro diagnostic medical devices in the EU
Legacy in-vitro diagnostic devices must comply with IVDR by 26 May 2026. Learn key deadlines, QMS requirements, and how Obelis can support your transition.
In-country representative for cosmetics sold on Canadian market
Discover Health Canada’s update requiring a Canadian-based representative for foreign cosmetic brands and how Obelis can help with compliance.
EU PMS requirements for medical devices under scrutiny of Dutch authority
Dutch audits reveal non-compliance with EU post-market surveillance (PMS) requirements for medical devices. Learn how to strengthen PMS systems for compliance and safety.
Upcoming February 2025 cosmetics deadlines: amendments to Annex II and Annex III
Key February 2025 alert for the cosmetics industry: new EU rules restrict ingredients like Genistein, Kojic Acid, and Alpha-Arbutin under Annex III and ban specific nanomaterials under Annex II.